These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11974973)

  • 1. Rehabilitation of hearing and communication functions in patients with NF2.
    Kuchta J; Behr R; Walger M; Michel O; Klug N
    Acta Neurochir Suppl; 2002; 79():109-11. PubMed ID: 11974973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hearing rehabilitation in neurofibromatosis type 2 patients: cochlear versus auditory brainstem implantation.
    Vincenti V; Pasanisi E; Guida M; Di Trapani G; Sanna M
    Audiol Neurootol; 2008; 13(4):273-80. PubMed ID: 18259080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auditory brainstem implants in NF2 patients: results and review of the literature.
    Sanna M; Di Lella F; Guida M; Merkus P
    Otol Neurotol; 2012 Feb; 33(2):154-64. PubMed ID: 22246383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auditory outcomes in tumor vs. nontumor patients fitted with auditory brainstem implants.
    Colletti V
    Adv Otorhinolaryngol; 2006; 64():167-185. PubMed ID: 16891842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multichannel auditory brain stem implant: performance in twenty patients.
    Otto SR; Shannon RV; Brackmann DE; Hitselberger WE; Staller S; Menapace C
    Otolaryngol Head Neck Surg; 1998 Mar; 118(3 Pt 1):291-303. PubMed ID: 9527106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The retrosigmoid approach for auditory brainstem implantation.
    Colletti V; Fiorino FG; Carner M; Giarbini N; Sacchetto L; Cumer G
    Am J Otol; 2000 Nov; 21(6):826-36. PubMed ID: 11078071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a multichannel auditory brainstem implant for neurofibromatosis type 2.
    Schwartz MS; Otto SR; Brackmann DE; Hitselberger WE; Shannon RV
    Stereotact Funct Neurosurg; 2003; 81(1-4):110-4. PubMed ID: 14742973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auditory brainstem implants for neurofibromatosis type 2.
    Colletti L; Shannon R; Colletti V
    Curr Opin Otolaryngol Head Neck Surg; 2012 Oct; 20(5):353-7. PubMed ID: 22886036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cochlear nucleus auditory prostheses.
    McCreery DB
    Hear Res; 2008 Aug; 242(1-2):64-73. PubMed ID: 18207678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cochlear implantation and auditory brainstem implantation in neurofibromatosis type 2.
    Peng KA; Lorenz MB; Otto SR; Brackmann DE; Wilkinson EP
    Laryngoscope; 2018 Sep; 128(9):2163-2169. PubMed ID: 29573425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.
    Carlson ML; Breen JT; Driscoll CL; Link MJ; Neff BA; Gifford RH; Beatty CW
    Otol Neurotol; 2012 Jul; 33(5):853-62. PubMed ID: 22664900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprosthetic hearing with auditory brainstem implants.
    Kuchta J
    Biomed Tech (Berl); 2004 Apr; 49(4):83-7. PubMed ID: 15171587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multichannel auditory brainstem implant: update on performance in 61 patients.
    Otto SR; Brackmann DE; Hitselberger WE; Shannon RV; Kuchta J
    J Neurosurg; 2002 Jun; 96(6):1063-71. PubMed ID: 12066908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. English consensus protocol evaluating candidacy for auditory brainstem and cochlear implantation in neurofibromatosis type 2.
    Tysome JR; Axon PR; Donnelly NP; Evans DG; Ferner RE; O'Connor AF; Freeman SR; Gleeson M; Halliday D; Harris F; Jiang D; Kerr R; King A; Knight RD; Lloyd SK; Macfarlane R; Mannion R; Mawman D; O'Driscoll M; Parry A; Ramsden J; Ramsden R; Rutherford SA; Saeed SR; Thomas N; Vanat ZH
    Otol Neurotol; 2013 Dec; 34(9):1743-7. PubMed ID: 24136318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial auditory and cognitive effects of auditory brainstem implantation in children.
    Colletti L
    Acta Otolaryngol; 2007 Sep; 127(9):943-6. PubMed ID: 17712673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auditory brainstem implant in neurofibromatosis type 2 and non-neurofibromatosis type 2 patients.
    Grayeli AB; Kalamarides M; Bouccara D; Ambert-Dahan E; Sterkers O
    Otol Neurotol; 2008 Dec; 29(8):1140-6. PubMed ID: 18849886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auditory brainstem implants.
    Schwartz MS; Otto SR; Shannon RV; Hitselberger WE; Brackmann DE
    Neurotherapeutics; 2008 Jan; 5(1):128-36. PubMed ID: 18164492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cochlear implants in the management of hearing loss in Neurofibromatosis Type 2.
    Harris F; Tysome JR; Donnelly N; Durie-Gair J; Crundwell G; Tam YC; Knight RD; Vanat ZH; Folland N; Axon P
    Cochlear Implants Int; 2017 May; 18(3):171-179. PubMed ID: 28335700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in restoration of hearing with the auditory brainstem implant.
    Colletti V; Shannon RV; Carner M; Veronese S; Colletti L
    Prog Brain Res; 2009; 175():333-45. PubMed ID: 19660666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Cochlear Implant Performance Prognostic Test Based on Electrical Field Interactions Evaluated by eABR (Electrical Auditory Brainstem Responses).
    Guevara N; Hoen M; Truy E; Gallego S
    PLoS One; 2016; 11(5):e0155008. PubMed ID: 27149268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.